-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hemophilia Inhibitor Prevention and Management

PhD Trainee  Ticketed Session
Program: How I Treat: Bringing Science to Clinical Dilemmas
Sunday, December 6, 2015: 11:15 AM-12:15 PM
Bayhill 21 (Hyatt Regency Orlando)
Speaker:
Rebecca Kruse-Jarres, MD, MPH, University of Washington

Disclosures:
Kruse-Jarres: Pfizer: Consultancy , Honoraria ; Novo Nordisk: Consultancy , Honoraria ; Roche: Consultancy , Honoraria ; CSL Behring: Consultancy , Honoraria ; Octapharma: Consultancy , Honoraria ; Bayer: Consultancy , Honoraria ; Baxter: Consultancy , Honoraria .
See more of: How I Treat: Bringing Science to Clinical Dilemmas
<< Previous Session | Next Session >>